Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.48B |
| 2 |
Apple
AAPL
|
+$610M |
| 3 |
Amazon
AMZN
|
+$538M |
| 4 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$379M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$337M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
| 2 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$466M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$420M |
| 4 |
Tesla
TSLA
|
+$251M |
| 5 |
IPHI
INPHI CORPORATION
IPHI
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.39% |
| 2 | Financials | 7.95% |
| 3 | Communication Services | 5.87% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Healthcare | 5.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
Monarch Casino & Resort
MCRI
$2.23B
| $976K | ﹤0.01% |
14,740
-13,408
| -48% | -$926K |
|
2652
Purple Innovation
PRPL
$41.7M
| $975K | ﹤0.01% |
1,478
-151
| -9% | -$116K |
|
2653
AAR Corp
AIR
$5.76B
| $973K | ﹤0.01% |
25,096
-24,985
| -50% | -$1.01M |
|
2654
Lantheus
LNTH
$6.59B
| $971K | ﹤0.01% |
35,106
-48,607
| -58% | -$1.12M |
|
2655
Moelis & Co
MC
$4.94B
| $971K | ﹤0.01% |
17,047
-46,659
| -73% | -$2.53M |
|
2656
AZZ Inc
AZZ
$4.54B
| $970K | ﹤0.01% |
18,737
-16,365
| -47% | -$860K |
|
2657
TechTarget
TTGT
$278M
| $970K | ﹤0.01% |
12,521
-17,768
| -59% | -$1.28M |
|
2658
First Trust NASDAQ Clean Edge Green Energy Index Fund
QCLN
$634M
| $969K | ﹤0.01% |
+14,000
| New | +$890K |
|
|
CHS
2659
DELISTED
Chicos FAS, Inc.
CHS
| $969K | ﹤0.01% |
147,327
-18,056
| -11% | -$77.8K |
|
|
CO
2660
DELISTED
Global Cord Blood Corporation
CO
| $967K | ﹤0.01% |
181,057
+86,925
| +92% | +$455K |
|
2661
iRhythm Holdings
IRTC
$4.2B
| $962K | ﹤0.01% |
14,485
-18,874
| -57% | -$1.5M |
|
|
MFA
2662
MFA Financial
MFA
$933M
| $962K | ﹤0.01% |
52,442
-74,304
| -59% | -$1.31M |
|
2663
Invesco S&P 500 Pure Value ETF
RPV
$1.68B
| $961K | ﹤0.01% |
+12,452
| New | +$972K |
|
|
AIF
2664
DELISTED
Apollo Tactical Income Fund Inc.
AIF
| $960K | ﹤0.01% |
57,409
+5,519
| +11% | +$84.2K |
|
2665
Cannae Holdings
CNNE
$649M
| $959K | ﹤0.01% |
28,266
-71,416
| -72% | -$2.66M |
|
|
SPTN
2666
DELISTED
SpartanNash
SPTN
| $959K | ﹤0.01% |
49,640
-36,205
| -42% | -$722K |
|
2667
PUT
Thermo Fisher Scientific
TMO
$220B
| $958K | ﹤0.01% |
1,900
| – | – |
|
2668
Herc Holdings
HRI
$5.61B
| $956K | ﹤0.01% |
8,528
-15,165
| -64% | -$1.6M |
|
2669
TG Therapeutics
TGTX
$7.62B
| $956K | ﹤0.01% |
24,643
-96,666
| -80% | -$3.8M |
|
2670
Universal Electronics
UEIC
$60.1M
| $952K | ﹤0.01% |
19,650
+446
| +2% | +$23.1K |
|
|
BPMC
2671
DELISTED
Blueprint Medicines
BPMC
| $949K | ﹤0.01% |
10,807
-44,861
| -81% | -$4.11M |
|
2672
Adaptive Biotechnologies
ADPT
$3.97B
| $947K | ﹤0.01% |
23,172
-45,918
| -66% | -$1.79M |
|
2673
Northwest Natural Holdings
NWN
$2.12B
| $943K | ﹤0.01% |
17,949
-24,323
| -58% | -$1.32M |
|
|
KW
2674
DELISTED
Kennedy-Wilson Holdings
KW
| $942K | ﹤0.01% |
47,468
-69,191
| -59% | -$1.4M |
|
2675
PUT
Diamondback Energy
FANG
$52.7B
| $939K | ﹤0.01% |
10,000
-69,400
| -87% | -$5.72M |
|
Similar funds
Barclays's Q2 2021 Portfolio in Review
As of Q2 2021, Barclays held 5,234 positions worth $212B, up 14% from $186B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Barclays deployed $11.1B of net new capital in Q2 2021, opening 558 new positions and adding to 1,559 existing holdings. Its largest new stake was Proofpoint, Inc.: 1,241,690 shares worth $216M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.14B trimmed.
- Barclays's largest Q2 2021 buy was Proofpoint, Inc.: 1,241,690 shares worth $216M.
- Barclays added most to iShares US Real Estate ETF in Q2 2021, an estimated $1.48B increase.
- Barclays's biggest Q2 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.14B.
- Barclays fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $466M.
- Barclays's ten largest holdings make up 36% of its $212B portfolio in Q2 2021.
- Barclays opened 558 new positions and closed 327 in Q2 2021.
- Barclays's portfolio value rose 14% quarter-over-quarter to $212B.
Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.